| http://dbpedia.org/ontology/abstract
|
ミチグリニド は、グリニド系経口血糖降下薬の一つ。2型糖尿病の治療に用いられる。 ミチグリニドは、（スルホニルウレア受容体）を刺激し、膵臓のβ細胞からインスリンを放出させるグリニド系に分類される。キッセイ薬品工業が開発したミチグリニドのが製剤化され、日本、ヨルダン、韓国で発売されている。日本では武田薬品工業とキッセイ薬品工業から、「グルファスト」として同一ブランド名で併売されている。
, Mitiglinide (INN, trade name Glufast) is a … Mitiglinide (INN, trade name Glufast) is a drug for the treatment of type 2 diabetes. Mitiglinide belongs to the meglitinide (glinide) class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to mitiglinide are held by Elixir Pharmaceuticals. Mitiglinide has not yet gained FDA approval.tiglinide has not yet gained FDA approval.
|
| http://dbpedia.org/ontology/alternativeName
|
Glufast
|
| http://dbpedia.org/ontology/casNumber
|
145375-43-5
|
| http://dbpedia.org/ontology/chEMBL
|
471498
|
| http://dbpedia.org/ontology/drugbank
|
DB01252
|
| http://dbpedia.org/ontology/fdaUniiCode
|
D86I0XLB13
|
| http://dbpedia.org/ontology/kegg
|
D01854
|
| http://dbpedia.org/ontology/pubchem
|
121891
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Mitiglinide.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.elixirpharm.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
7873418
|
| http://dbpedia.org/ontology/wikiPageLength
|
3102
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1061775899
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Meglitinide +
, http://dbpedia.org/resource/Insulin +
, http://dbpedia.org/resource/ATP-sensitive_potassium_channel +
, http://dbpedia.org/resource/Category:Potassium_channel_blockers +
, http://dbpedia.org/resource/Takeda_Pharmaceutical_Company +
, http://dbpedia.org/resource/Category:Isoindoles +
, http://dbpedia.org/resource/Category:Carboxamides +
, http://dbpedia.org/resource/Diabetes_mellitus_type_2 +
, http://dbpedia.org/resource/Tablet_%28pharmacy%29 +
, http://dbpedia.org/resource/Beta_cell +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Kissei +
, http://dbpedia.org/resource/International_nonproprietary_name +
, http://dbpedia.org/resource/Drug +
, http://dbpedia.org/resource/Category:Meglitinides +
, http://dbpedia.org/resource/Oral_administration +
|
| http://dbpedia.org/property/atcPrefix
|
A10
|
| http://dbpedia.org/property/atcSuffix
|
BX08
|
| http://dbpedia.org/property/c
|
19
|
| http://dbpedia.org/property/casNumber
|
145375
|
| http://dbpedia.org/property/chembl
|
471498
|
| http://dbpedia.org/property/chemspiderid
|
108739
|
| http://dbpedia.org/property/drugbank
|
DB01252
|
| http://dbpedia.org/property/h
|
25
|
| http://dbpedia.org/property/iupacName
|
--α-Benzylhexahydro-γ-oxo-2-isoindolinebutyric acid
|
| http://dbpedia.org/property/kegg
|
D01854
|
| http://dbpedia.org/property/n
|
1
|
| http://dbpedia.org/property/o
|
3
|
| http://dbpedia.org/property/pubchem
|
121891
|
| http://dbpedia.org/property/routesOfAdministration
|
By mouth
|
| http://dbpedia.org/property/smiles
|
O=C[C@@H]CCN3C[C@H]2CCCC[C@H]2C3
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
WPGGHFDDFPHPOB-BBWFWOEESA-N
|
| http://dbpedia.org/property/tradename
|
Glufast
|
| http://dbpedia.org/property/unii
|
D86I0XLB13
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
462252797
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Keggcite +
, http://dbpedia.org/resource/Template:Drugs.com +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Oral_hypoglycemics +
, http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Ion_channel_modulators +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Ebicite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Isoindoles +
, http://dbpedia.org/resource/Category:Meglitinides +
, http://dbpedia.org/resource/Category:Carboxamides +
, http://dbpedia.org/resource/Category:Potassium_channel_blockers +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Mitiglinide?oldid=1061775899&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Mitiglinide.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Mitiglinide +
|
| owl:sameAs |
http://sr.dbpedia.org/resource/Mitiglinid +
, http://yago-knowledge.org/resource/Mitiglinide +
, http://rdf.freebase.com/ns/m.026h2kt +
, http://www4.wiwiss.fu-berlin.de/drugbank/resource/drugs/DB01252 +
, http://dbpedia.org/resource/Mitiglinide +
, http://www.wikidata.org/entity/Q266321 +
, https://global.dbpedia.org/id/2VStv +
, http://ja.dbpedia.org/resource/%E3%83%9F%E3%83%81%E3%82%B0%E3%83%AA%E3%83%8B%E3%83%89 +
, http://sh.dbpedia.org/resource/Mitiglinid +
|
| rdf:type |
http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Amide114724264 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/WikicatAmides +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://umbel.org/umbel/rc/DrugProduct +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
|
| rdfs:comment |
ミチグリニド は、グリニド系経口血糖降下薬の一つ。2型糖尿病の治療に用いられる。 ミチグリニドは、（スルホニルウレア受容体）を刺激し、膵臓のβ細胞からインスリンを放出させるグリニド系に分類される。キッセイ薬品工業が開発したミチグリニドのが製剤化され、日本、ヨルダン、韓国で発売されている。日本では武田薬品工業とキッセイ薬品工業から、「グルファスト」として同一ブランド名で併売されている。
, Mitiglinide (INN, trade name Glufast) is a … Mitiglinide (INN, trade name Glufast) is a drug for the treatment of type 2 diabetes. Mitiglinide belongs to the meglitinide (glinide) class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to mitiglinide are held by Elixir Pharmaceuticals. Mitiglinide has not yet gained FDA approval.tiglinide has not yet gained FDA approval.
|
| rdfs:label |
Mitiglinide
, ミチグリニド
|
